Literature DB >> 29324313

Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.

Shi-Lei Tang1, Yuan-Lin Gao2, Hu Wen-Zhong3.   

Abstract

Tripartite motif 37 (TRIM37), a member of the TRIM protein family, was involved in the tumorigenesis of several types of cancer. However, the expression pattern and role of TRIM37 in glioma remain unclear. Therefore, the aim of the present study was to investigate the role of TRIM37 in glioma, and to determine the molecular mechanisms. Our results demonstrated that TRIM37 was highly expressed in human glioma tissues and cell liens. Additionally, knockdown of TRIM37 dramatically inhibited the proliferation, migration/invasion, and the epithelial-mesenchymal transition (EMT) phenotype in glioma cells. Furthermore, knockdown of TRIM37 significantly reduced the levels of phosphorylated PI3K and Akt in U87MG cells, and an activator of PI3K/Akt signaling (SC79) partly reversed the inhibitory effects of si-TRIM37 on glioma cell proliferation and migration. Taken together, our results demonstrated that TRIM37 functions as an oncogene in the development and progression of glioma. TRIM37 knockdown inhibited the proliferation and invasion of human glioma cells at least in part through the inactivation of PI3K/Akt signaling pathway.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  EMT; Glioma; Invasion; TRIM37

Mesh:

Substances:

Year:  2018        PMID: 29324313     DOI: 10.1016/j.biopha.2018.01.054

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  21 in total

1.  ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.

Authors:  Tao Fu; Ke Ji; Li Jin; Ji Zhang; Xiaojiang Wu; Xin Ji; Biao Fan; Ziyu Jia; Anqiang Wang; Jiaen Liu; Zhaode Bu; Jiafu Ji
Journal:  Gastric Cancer       Date:  2020-06-22       Impact factor: 7.370

Review 2.  The TRIM proteins in cancer: from expression to emerging regulatory mechanisms.

Authors:  A Mohammadi; M S Pour Abbasi; S Khorrami; S Khodamoradi; Z Mohammadi Goldar; F Ebrahimzadeh
Journal:  Clin Transl Oncol       Date:  2021-10-13       Impact factor: 3.405

3.  TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.

Authors:  Guimei Cui; Zhuoran Gao; Shiehong Chang; Nitin Narwade; Yitian Chen; Barun Poudel; Kate M K Lei; Weibo Zhang; Gang Li; Terence C W Poon; Edwin Cheung
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

Review 4.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

5.  TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial-mesenchymal transition in gastric cancer.

Authors:  Dehu Chen; Xiaolan You; Yan Pan; Qinghong Liu; Gan Cao
Journal:  Onco Targets Ther       Date:  2018-12-10       Impact factor: 4.147

6.  TRIM37 targets AKT in the growth of lung cancer cells.

Authors:  Shumin Dong; Xueqin Pang; Haijun Sun; Chunluan Yuan; Chuanyong Mu; Shiying Zheng
Journal:  Onco Targets Ther       Date:  2018-11-08       Impact factor: 4.147

Review 7.  E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis.

Authors:  Santina Venuto; Giuseppe Merla
Journal:  Cells       Date:  2019-05-27       Impact factor: 6.600

8.  Exploring the genetics of trotting racing ability in horses using a unique Nordic horse model.

Authors:  Brandon D Velie; Mette Lillie; Kim Jäderkvist Fegraeus; Maria K Rosengren; Marina Solé; Maja Wiklund; Carl-Fredrik Ihler; Eric Strand; Gabriella Lindgren
Journal:  BMC Genomics       Date:  2019-02-04       Impact factor: 3.969

9.  Knockdown of TRIM37 Promotes Apoptosis and Suppresses Tumor Growth in Gastric Cancer by Inactivation of the ERK1/2 Pathway.

Authors:  Hongyi Zhu; Yuanwen Chen; Jie Zhang; Changlin Qian; Weiqing Qiu; Huojian Shen; Zhiyong Shen
Journal:  Onco Targets Ther       Date:  2020-06-12       Impact factor: 4.147

10.  Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT.

Authors:  Bin Wang; Gang Wang; Qingfeng Wang; Ziqiang Zhu; Yunqing Wang; Kangwu Chen; Huilin Yang
Journal:  Cancer Cell Int       Date:  2019-11-08       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.